162 related articles for article (PubMed ID: 26934960)
1. Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors.
Yan J; Dong J; Wu J; Zhu R; Wang Z; Wang B; Wang L; Wang Z; Zhang H; Wu H; Yu B; Kong W; Yu X
Sci Rep; 2016 Mar; 6():22464. PubMed ID: 26934960
[TBL] [Abstract][Full Text] [Related]
2. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions.
Bradley RR; Maxfield LF; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(2):1267-72. PubMed ID: 22072746
[TBL] [Abstract][Full Text] [Related]
4. Chimeric hexon HVRs protein reflects partial function of adenovirus.
Yu B; Wang C; Dong J; Zhang M; Zhang H; Wu J; Wu Y; Kong W; Yu X
Biochem Biophys Res Commun; 2012 May; 421(2):170-6. PubMed ID: 22490664
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection.
Bradley RR; Lynch DM; Iampietro MJ; Borducchi EN; Barouch DH
J Virol; 2012 Jan; 86(1):625-9. PubMed ID: 22072776
[TBL] [Abstract][Full Text] [Related]
6. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.
Bruder JT; Chen P; Semenova E; Thomas CA; Konovalova S; Ekberg G; Ettyreddy D; McVey D; Gall JG; King CR; Brough DE
J Virol; 2013 Sep; 87(17):9661-71. PubMed ID: 23824800
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism of Adenovirus Late Protein L4-100K Chaperones the Trimerization of Hexon.
Zhu R; Xu XG; Zhang TX; Wang XP; Zhang CH; Wang CY; Wang C; Wu JX; Yu B; Yu XH
J Virol; 2023 Jan; 97(1):e0146722. PubMed ID: 36475768
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity.
Thorner AR; Lemckert AA; Goudsmit J; Lynch DM; Ewald BA; Denholtz M; Havenga MJ; Barouch DH
J Virol; 2006 Dec; 80(24):12009-16. PubMed ID: 17035318
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon.
Tian X; Su X; Li H; Li X; Zhou Z; Liu W; Zhou R
Virus Res; 2011 Sep; 160(1-2):214-20. PubMed ID: 21740937
[TBL] [Abstract][Full Text] [Related]
11. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
[TBL] [Abstract][Full Text] [Related]
12. Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors.
Teigler JE; Penaloza-MacMaster P; Obeng R; Provine NM; Larocca RA; Borducchi EN; Barouch DH
Clin Vaccine Immunol; 2014 Aug; 21(8):1137-44. PubMed ID: 24943382
[TBL] [Abstract][Full Text] [Related]
13. Identification of sites in adenovirus hexon for foreign peptide incorporation.
Wu H; Han T; Belousova N; Krasnykh V; Kashentseva E; Dmitriev I; Kataram M; Mahasreshti PJ; Curiel DT
J Virol; 2005 Mar; 79(6):3382-90. PubMed ID: 15731232
[TBL] [Abstract][Full Text] [Related]
14. The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses.
Hong SS; Szolajska E; Schoehn G; Franqueville L; Myhre S; Lindholm L; Ruigrok RW; Boulanger P; Chroboczek J
J Mol Biol; 2005 Sep; 352(1):125-38. PubMed ID: 16081097
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.
Nanda A; Lynch DM; Goudsmit J; Lemckert AA; Ewald BA; Sumida SM; Truitt DM; Abbink P; Kishko MG; Gorgone DA; Lifton MA; Shen L; Carville A; Mansfield KG; Havenga MJ; Barouch DH
J Virol; 2005 Nov; 79(22):14161-8. PubMed ID: 16254351
[TBL] [Abstract][Full Text] [Related]
16. Manipulating adenovirus hexon hypervariable loops dictates immune neutralisation and coagulation factor X-dependent cell interaction in vitro and in vivo.
Ma J; Duffy MR; Deng L; Dakin RS; Uil T; Custers J; Kelly SM; McVey JH; Nicklin SA; Baker AH
PLoS Pathog; 2015 Feb; 11(2):e1004673. PubMed ID: 25658827
[TBL] [Abstract][Full Text] [Related]
17. Hexon gene switch strategy for the generation of chimeric recombinant adenovirus.
Youil R; Toner TJ; Su Q; Chen M; Tang A; Bett AJ; Casimiro D
Hum Gene Ther; 2002 Jan; 13(2):311-20. PubMed ID: 11812286
[TBL] [Abstract][Full Text] [Related]
18. Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
Harmon AW; Moitra R; Xu Z; Byrnes AP
PLoS One; 2018; 13(2):e0192353. PubMed ID: 29401488
[TBL] [Abstract][Full Text] [Related]
19. Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer.
Alba R; Bradshaw AC; Parker AL; Bhella D; Waddington SN; Nicklin SA; van Rooijen N; Custers J; Goudsmit J; Barouch DH; McVey JH; Baker AH
Blood; 2009 Jul; 114(5):965-71. PubMed ID: 19429866
[TBL] [Abstract][Full Text] [Related]
20. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.
Rux JJ; Burnett RM
Mol Ther; 2000 Jan; 1(1):18-30. PubMed ID: 10933908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
